• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华法林与环糊精形成包合物以改善某些药物特性。

Inclusion complexation of warfarin with cyclodextrins to improve some pharmaceutical characteristics.

作者信息

Lin S Y, Yang J C

出版信息

Pharm Weekbl Sci. 1986 Aug 22;8(4):223-8. doi: 10.1007/BF01957782.

DOI:10.1007/BF01957782
PMID:3763366
Abstract

Inclusion complexation of warfarin and alpha- or beta-cyclodextrins in water and in the solid phase were studied by a solubility method, a membrane permeation study, thin-layer chromatography, a dissolution study, IR spectroscopy and differential scanning calorimetry. The solubility of warfarin increased with the addition of cyclodextrins. The apparent stability constants of the alpha- and beta-cyclodextrin complexes are 10.29 M-1 and 148.88 M-1, respectively. The greater the stability constant of the inclusion complex the lesser the permeability of warfarin. Solid complexes of warfarin and alpha- or beta-cyclodextrins were obtained by freeze-drying. Clear differences in IR absorption spectra and DSC thermograms were observed between the inclusion complexes and physical mixtures. The dissolution rate of the freeze-dried warfarin-cyclodextrin complexes was increased about 1200-fold and 550-fold for alpha- and beta-cyclodextrins, respectively. The dissolution rate of warfarin was significantly improved by complex formation.

摘要

通过溶解度法、膜渗透研究、薄层色谱法、溶出度研究、红外光谱法和差示扫描量热法,研究了华法林与α-或β-环糊精在水相和固相中形成包合物的情况。加入环糊精后,华法林的溶解度增加。α-和β-环糊精配合物的表观稳定常数分别为10.29 M-1和148.88 M-1。包合物的稳定常数越大,华法林的渗透性越小。通过冷冻干燥得到了华法林与α-或β-环糊精的固体配合物。在包合物和物理混合物之间观察到红外吸收光谱和DSC热谱图存在明显差异。对于α-和β-环糊精,冷冻干燥的华法林-环糊精配合物的溶出速率分别提高了约1200倍和550倍。通过形成配合物,华法林的溶出速率得到显著提高。

相似文献

1
Inclusion complexation of warfarin with cyclodextrins to improve some pharmaceutical characteristics.华法林与环糊精形成包合物以改善某些药物特性。
Pharm Weekbl Sci. 1986 Aug 22;8(4):223-8. doi: 10.1007/BF01957782.
2
Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.1,2 - 二硫杂环戊烯 - 3 - 硫酮与β - 环糊精及其羟丙基和磺丁基醚 - 7衍生物络合后溶解度和溶解速率的提高。
J Pharm Sci. 1999 Sep;88(9):889-95. doi: 10.1021/js990067o.
3
Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.华法林-β-环糊精包合物的处方前研究
Int J Pharm. 2005 Mar 3;291(1-2):3-10. doi: 10.1016/j.ijpharm.2004.11.013. Epub 2004 Dec 28.
4
Mechanism of drug dissolution rate enhancement from beta-cyclodextrin-drug systems.β-环糊精-药物体系提高药物溶解速率的机制
J Pharm Pharmacol. 1982 Oct;34(10):621-6. doi: 10.1111/j.2042-7158.1982.tb04689.x.
5
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.他达拉非与天然及化学修饰的β-环糊精的包合物。I:制备及体外评价
Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.
6
Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.孕酮 - 环糊精 - 聚合物体系的溶解度和溶解速率
Drug Dev Ind Pharm. 2006 Oct;32(9):1043-58. doi: 10.1080/03639040600897093.
7
Complexation of ursodeoxycholic acid with beta-cyclodextrin-choline dichloride coprecipitate.熊去氧胆酸与β-环糊精-二氯化胆碱共沉淀物的络合作用。
Int J Pharm. 1999 Nov 15;190(2):139-53. doi: 10.1016/s0378-5173(99)00205-7.
8
Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.通过与七(2,6-二-O-甲基)-β-环糊精形成包合物改善氟比洛芬的溶出度和栓剂释放特性。
J Pharm Sci. 1985 Aug;74(8):841-5. doi: 10.1002/jps.2600740808.
9
Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.通过与β-环糊精络合改善呋塞米的溶解性能。
Drug Dev Ind Pharm. 1998 Jan;24(1):19-25. doi: 10.3109/03639049809082348.
10
In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.长春西汀与羟丙基-β-环糊精复合物的体外和体内研究。
Arch Pharm Res. 2007 Aug;30(8):991-1001. doi: 10.1007/BF02993968.

本文引用的文献

1
Stoichiometric model of alpha-cyclodextrin complex formation.α-环糊精复合物形成的化学计量模型。
J Pharm Sci. 1980 May;69(5):564-7. doi: 10.1002/jps.2600690524.
2
[Pharmaceutical applications of cyclodextrin complexations (author's transl)].环糊精包合作用的药物应用(作者译)
Yakugaku Zasshi. 1981 Oct;101(10):857-73. doi: 10.1248/yakushi1947.101.10_857.
3
Improvements to some pharmaceutical properties of flurbiprofen by beta- and gamma-cyclodextrin complexations.通过β-环糊精和γ-环糊精包合作用改善氟比洛芬的某些药物性质。
Acta Pharm Suec. 1983;20(1):1-10.
4
Biopharmaceutical study of inclusion complexes. I. Pharmaceutical advantages of cyclodextrin complexes of bencyclane fumarate.包合物的生物制药研究。I. 富马酸苄环烷环糊精复合物的药学优势。
Chem Pharm Bull (Tokyo). 1983 Jul;31(7):2416-23. doi: 10.1248/cpb.31.2416.
5
Dissolution and ionization of warfarin.华法林的溶解与电离
J Pharm Sci. 1984 Jul;73(7):946-8. doi: 10.1002/jps.2600730721.
6
In vivo and in vitro availability of commercial warfarin tablets.市售华法林片剂的体内和体外生物利用度
J Pharm Sci. 1971 May;60(5):666-77. doi: 10.1002/jps.2600600503.
7
Bioavailability of dicumarol from different commercial tablets in dogs.不同市售片剂中双香豆素在犬体内的生物利用度。
J Pharm Sci. 1973 Jul;62(7):1192-3. doi: 10.1002/jps.2600620730.
8
Effect of coadministration of aluminum and magnesium hydroxides on absorption of anticoagulants in man.氢氧化铝和氢氧化镁联合给药对人体抗凝剂吸收的影响。
Clin Pharmacol Ther. 1973 Mar-Apr;14(2):231-7. doi: 10.1002/cpt1973142231.
9
Interaction between warfarin and nonsteroidal anti-inflammatory drugs (NSAIDs) in rats.华法林与非甾体抗炎药(NSAIDs)在大鼠体内的相互作用。
Life Sci. 1985 Mar 18;36(11):1041-50. doi: 10.1016/0024-3205(85)90489-8.
10
Structure of warfarin in solution.溶液中华法林的结构。
J Med Chem. 1977 Nov;20(11):1489-93. doi: 10.1021/jm00221a025.